• stock_research59
    $DRRX Don't know why FDA denied POSIDUR? It is almost exactly like Pacira's EXPAREL. Now strong buying opportunity!
    Reply (2)
    • NoviceInvestor1: FDA wants another clinical study to verify safety for labeled uses, this is not unusual for the FDA. Just delays approval
    • stock_research59: That's just great. Now I have to wait another two years until this takes off!